Corinna Schultz

Has grant

Interim Chief

Nemours Children's Health System

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Corinna Schultz is the Interim Chief at Nemours Children's Health System in the United States. Her research areas encompass pediatric oncology, thrombosis prevention, and the impact of social determinants of health in healthcare delivery. Recent publications include studies on the efficacy of apixaban in pediatric patients and the management of heavy menstrual bleeding related to inherited bleeding disorders. She is also focused on addressing persistent disparities in pediatric healthcare engagement observed during the COVID-19 pandemic.

Recent Grants

Grant: Close

The Delaware Comprehensive Sickle Cell Research Center

Open Date: 2014-08-01

Close Date: 2026-06-30

Articles (13)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Collaborators (6)

Etan Orgel

Associate Professor of Clinical Pediatrics

University of Southern California

UNITED STATES

View details

Melissa Alderfer

Professor

Sidney Kimmel Medical College at Thomas Jefferson University

UNITED STATES

View details

Robert J. Klaassen

CANADA

View details

Jennifer Rothman

Duke University

UNITED STATES

View details

Nancy Kassam-Adams

Research Professor

University of Pennsylvania

UNITED STATES

View details

Glaivy Batsuli

Assistant Professor

Stanford University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Corinna Schultz

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (13)

Safety and efficacy of apixaban thrombosis prevention in pediatric patients with obesity and acute lymphoblastic leukemia

What's in a name: defining pediatric refractory ITP

Social Determinants of Health in Cardio-Oncology

Apixaban versus no anticoagulation for the prevention of venous thromboembolism in children with newly diagnosed acute lymphoblastic leukaemia or lymphoma (PREVAPIX-ALL): a phase 3, open-label, randomised, controlled trial

Knowledge and Confidence of Obstetrics and Gynecology Residents in the Evaluation and Management of Heavy Menstrual Bleeding Due to Inherited Bleeding Disorders

Persistent Disparities in Pediatric Health Care Engagement During the COVID-19 Pandemic

Cerebral revascularization surgery reduces cerebrovascular events in children with sickle cell disease and moyamoya syndrome: Results of the stroke in sickle cell revascularization surgery retrospective study

COVID-19 Exposure and Family Impact Scales for Adolescents and Young Adults

Family‐centered communication in pediatric sickle cell disease

Attitudes and Practices of Pediatric Oncologists Regarding Palliative Care Consultation for Pediatric Oncology Patients

Online patient portal use by caregivers in pediatric oncology: Are we widening sociodemographic disparities?

Use of plasma‐derived factor X concentrate in neonates and infants with congenital factor X deficiency

Reproductive intentions in mothers of young children with sickle cell disease

Collaborators (6)

Etan Orgel

Melissa Alderfer

Robert J. Klaassen

Jennifer Rothman

Nancy Kassam-Adams

Glaivy Batsuli

Make your next move.